The urolithiasis management devices market size has grown strongly in recent years. It will grow from $1.69 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing incidence of kidney stone disease, expansion of urology departments, rising adoption of endoscopic stone management, advancements in lithotripsy technology, improved access to urological care.
The urolithiasis management devices market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive urology treatments, rising healthcare expenditure on specialty care, expansion of ambulatory surgical centers, technological advancements in laser lithotripsy, growing focus on faster recovery procedures. Major trends in the forecast period include increasing adoption of minimally invasive stone removal devices, rising demand for laser-based lithotripsy systems, growing use of flexible ureteroscopes, expansion of outpatient urology procedures, enhanced focus on treatment efficiency and patient recovery.
The increasing prevalence of chronic kidney disease (CKD) is expected to drive the growth of the urolithiasis management devices market going forward. CKD refers to the progressive deterioration of kidney function, which often leads to the formation of kidney stones due to impaired filtration, mineral imbalances, and a reduced ability to eliminate waste. As the global burden of CKD rises, the demand for medical devices that aid in managing and removing kidney stones, relieving obstructions, and improving patient outcomes also increases. For instance, in June 2023, according to Kidney Research UK, a UK-based charity dedicated to funding kidney disease research, the population affected by CKD stages 3-5 is projected to reach approximately 3.9 million by 2033. Therefore, the rising prevalence of chronic kidney disease is driving growth in the urolithiasis management devices market.
Key players in the urolithiasis management devices market are focusing on developing innovative technology-based products such as thulium fiber laser (TFL) technology-based laser machines to maintain a competitive advantage. Thulium Fiber Laser (TFL) technology is an advanced laser system utilized in the management and treatment of urolithiasis, or urinary stones. For instance, Coloplast AS launched the Coloplast TFL Drive in July 2023, marking the first laser product capable of pulverizing kidney stones into fine particles. This all-in-one thulium fiber laser system is designed for lithotripsy, BPH (Benign prostatic hyperplasia) treatment, and precise soft tissue procedures, offering faster, safer treatments with surgical versatility and highly effective intra-operative performance using the latest Thulium Fiber Laser (TFL) technology.
In September 2025, Olympus Corporation, a Japan-based medical technology company, partnered with MacroLux Medical to distribute single-use urology products globally. This collaboration aims to expand Olympus’s urology portfolio by providing innovative single-use devices that improve surgical precision, enhance safety, and streamline workflow efficiency. MacroLux Medical Technology Co. Ltd., a China-based company, specializes in urolithiasis management devices.
Major companies operating in the urolithiasis management devices market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Rocamed SAM, DirexGroup, Cook Medical Inc., Karl Storz SE & Co. KG, C. R. Bard Inc., MTS Medical LLC, Richard Wolf GmbH, Dornier MedTech GmbH, EDAP TMS, EMS Electro Medical Systems SA, Shenzhen Huikang Medical Apparatus, Storz Medical AG, Allengers Medical Systems, JenaSurgical GmbH, ELMED Medical Systems, Allium Medical Solutions Ltd., Elmed Lithotripsy Systems Inc.
North America was the largest region in the urolithiasis management devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urolithiasis management devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urolithiasis management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the urolithiasis management devices market by increasing costs of imported lasers, endoscopic components, imaging systems, and precision instruments used in lithotripters and ureteroscopes. Hospitals and urology clinics in North America and Europe are most affected due to reliance on imported advanced devices, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing capital equipment costs and slowing technology upgrades. However, they are also promoting domestic manufacturing, regional assembly of urology devices, and innovation in cost-optimized stone management solutions.
The urolithiasis management devices market research report is one of a series of new reports that provides urolithiasis management devices market statistics, including urolithiasis management devices industry global market size, regional shares, competitors with a urolithiasis management devices market share, detailed urolithiasis management devices market segments, market trends and opportunities, and any further data you may need to thrive in the urolithiasis management devices industry. This urolithiasis management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Urolithiasis management devices are medical instruments utilized in diagnosing, treating, and managing urolithiasis, which involves the formation of stones in the urinary tract. They primarily aid in retrieving, breaking, or assisting the passage of kidney stones, offering minimally invasive treatment options. These devices target the challenges associated with kidney stones by providing efficient and less invasive solutions for their management.
The main types of urolithiasis management devices include lithotripters and ureteroscopes. Lithotripters are medical devices that utilize shock waves or laser technology to break kidney stones into smaller fragments, facilitating their passage through the urinary tract. They are used in treatments such as extracorporeal shock wave lithotripsy (ESWL), intracorporeal lithotripsy, percutaneous nephrolithotomy, and others. These devices serve various end users, including hospitals, clinics, and ambulatory surgical centers.
The urolithiasis management devices market consists of sales of nephroscopes, stone retrieval baskets, stone extraction balloons, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The urolithiasis management devices market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive urology treatments, rising healthcare expenditure on specialty care, expansion of ambulatory surgical centers, technological advancements in laser lithotripsy, growing focus on faster recovery procedures. Major trends in the forecast period include increasing adoption of minimally invasive stone removal devices, rising demand for laser-based lithotripsy systems, growing use of flexible ureteroscopes, expansion of outpatient urology procedures, enhanced focus on treatment efficiency and patient recovery.
The increasing prevalence of chronic kidney disease (CKD) is expected to drive the growth of the urolithiasis management devices market going forward. CKD refers to the progressive deterioration of kidney function, which often leads to the formation of kidney stones due to impaired filtration, mineral imbalances, and a reduced ability to eliminate waste. As the global burden of CKD rises, the demand for medical devices that aid in managing and removing kidney stones, relieving obstructions, and improving patient outcomes also increases. For instance, in June 2023, according to Kidney Research UK, a UK-based charity dedicated to funding kidney disease research, the population affected by CKD stages 3-5 is projected to reach approximately 3.9 million by 2033. Therefore, the rising prevalence of chronic kidney disease is driving growth in the urolithiasis management devices market.
Key players in the urolithiasis management devices market are focusing on developing innovative technology-based products such as thulium fiber laser (TFL) technology-based laser machines to maintain a competitive advantage. Thulium Fiber Laser (TFL) technology is an advanced laser system utilized in the management and treatment of urolithiasis, or urinary stones. For instance, Coloplast AS launched the Coloplast TFL Drive in July 2023, marking the first laser product capable of pulverizing kidney stones into fine particles. This all-in-one thulium fiber laser system is designed for lithotripsy, BPH (Benign prostatic hyperplasia) treatment, and precise soft tissue procedures, offering faster, safer treatments with surgical versatility and highly effective intra-operative performance using the latest Thulium Fiber Laser (TFL) technology.
In September 2025, Olympus Corporation, a Japan-based medical technology company, partnered with MacroLux Medical to distribute single-use urology products globally. This collaboration aims to expand Olympus’s urology portfolio by providing innovative single-use devices that improve surgical precision, enhance safety, and streamline workflow efficiency. MacroLux Medical Technology Co. Ltd., a China-based company, specializes in urolithiasis management devices.
Major companies operating in the urolithiasis management devices market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Rocamed SAM, DirexGroup, Cook Medical Inc., Karl Storz SE & Co. KG, C. R. Bard Inc., MTS Medical LLC, Richard Wolf GmbH, Dornier MedTech GmbH, EDAP TMS, EMS Electro Medical Systems SA, Shenzhen Huikang Medical Apparatus, Storz Medical AG, Allengers Medical Systems, JenaSurgical GmbH, ELMED Medical Systems, Allium Medical Solutions Ltd., Elmed Lithotripsy Systems Inc.
North America was the largest region in the urolithiasis management devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urolithiasis management devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urolithiasis management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the urolithiasis management devices market by increasing costs of imported lasers, endoscopic components, imaging systems, and precision instruments used in lithotripters and ureteroscopes. Hospitals and urology clinics in North America and Europe are most affected due to reliance on imported advanced devices, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing capital equipment costs and slowing technology upgrades. However, they are also promoting domestic manufacturing, regional assembly of urology devices, and innovation in cost-optimized stone management solutions.
The urolithiasis management devices market research report is one of a series of new reports that provides urolithiasis management devices market statistics, including urolithiasis management devices industry global market size, regional shares, competitors with a urolithiasis management devices market share, detailed urolithiasis management devices market segments, market trends and opportunities, and any further data you may need to thrive in the urolithiasis management devices industry. This urolithiasis management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Urolithiasis management devices are medical instruments utilized in diagnosing, treating, and managing urolithiasis, which involves the formation of stones in the urinary tract. They primarily aid in retrieving, breaking, or assisting the passage of kidney stones, offering minimally invasive treatment options. These devices target the challenges associated with kidney stones by providing efficient and less invasive solutions for their management.
The main types of urolithiasis management devices include lithotripters and ureteroscopes. Lithotripters are medical devices that utilize shock waves or laser technology to break kidney stones into smaller fragments, facilitating their passage through the urinary tract. They are used in treatments such as extracorporeal shock wave lithotripsy (ESWL), intracorporeal lithotripsy, percutaneous nephrolithotomy, and others. These devices serve various end users, including hospitals, clinics, and ambulatory surgical centers.
The urolithiasis management devices market consists of sales of nephroscopes, stone retrieval baskets, stone extraction balloons, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Urolithiasis Management Devices Market Characteristics
3. Urolithiasis Management Devices Market Supply Chain Analysis
4. Global Urolithiasis Management Devices Market Trends and Strategies
5. Urolithiasis Management Devices Market Analysis of End Use Industries
7. Global Urolithiasis Management Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Urolithiasis Management Devices Total Addressable Market (TAM) Analysis for the Market
9. Urolithiasis Management Devices Market Segmentation
10. Urolithiasis Management Devices Market Regional and Country Analysis
11. Asia-Pacific Urolithiasis Management Devices Market
12. China Urolithiasis Management Devices Market
13. India Urolithiasis Management Devices Market
14. Japan Urolithiasis Management Devices Market
15. Australia Urolithiasis Management Devices Market
16. Indonesia Urolithiasis Management Devices Market
17. South Korea Urolithiasis Management Devices Market
18. Taiwan Urolithiasis Management Devices Market
19. South East Asia Urolithiasis Management Devices Market
20. Western Europe Urolithiasis Management Devices Market
21. UK Urolithiasis Management Devices Market
22. Germany Urolithiasis Management Devices Market
23. France Urolithiasis Management Devices Market
24. Italy Urolithiasis Management Devices Market
25. Spain Urolithiasis Management Devices Market
26. Eastern Europe Urolithiasis Management Devices Market
27. Russia Urolithiasis Management Devices Market
28. North America Urolithiasis Management Devices Market
29. USA Urolithiasis Management Devices Market
30. Canada Urolithiasis Management Devices Market
31. South America Urolithiasis Management Devices Market
32. Brazil Urolithiasis Management Devices Market
33. Middle East Urolithiasis Management Devices Market
34. Africa Urolithiasis Management Devices Market
36. Urolithiasis Management Devices Market Competitive Landscape and Company Profiles
37. Urolithiasis Management Devices Market Other Major and Innovative Companies
40. Urolithiasis Management Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Urolithiasis Management Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses urolithiasis management devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for urolithiasis management devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urolithiasis management devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Lithotripters; Ureteroscopes2) By Treatment Type: Extracorporeal Shock Wave Lithotripsy (ESWL); Intracorporeal Lithotripsy; Percutaneous Nephrolithotomy; Other Treatment Types
3) By End Users: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Lithotripters: Extracorporeal Shock Wave Lithotripters (Eswl); Laser Lithotripters; Pneumatic Lithotripters2) By Ureteroscopes: Rigid Ureteroscopes; Flexible Ureteroscopes
Companies Mentioned: Medtronic plc; Siemens Healthineers AG; Boston Scientific Corporation; Olympus Corporation; Rocamed SAM; DirexGroup; Cook Medical Inc.; Karl Storz SE & Co. KG; C. R. Bard Inc.; MTS Medical LLC; Richard Wolf GmbH; Dornier MedTech GmbH; EDAP TMS; EMS Electro Medical Systems SA; Shenzhen Huikang Medical Apparatus; Storz Medical AG; Allengers Medical Systems; JenaSurgical GmbH; ELMED Medical Systems; Allium Medical Solutions Ltd.; Elmed Lithotripsy Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Urolithiasis Management Devices market report include:- Medtronic plc
- Siemens Healthineers AG
- Boston Scientific Corporation
- Olympus Corporation
- Rocamed SAM
- DirexGroup
- Cook Medical Inc.
- Karl Storz SE & Co. KG
- C. R. Bard Inc.
- MTS Medical LLC
- Richard Wolf GmbH
- Dornier MedTech GmbH
- EDAP TMS
- EMS Electro Medical Systems SA
- Shenzhen Huikang Medical Apparatus
- Storz Medical AG
- Allengers Medical Systems
- JenaSurgical GmbH
- ELMED Medical Systems
- Allium Medical Solutions Ltd.
- Elmed Lithotripsy Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.79 Billion |
| Forecasted Market Value ( USD | $ 2.21 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
